Syngene International Ltd
NSE:SYNGENE

Watchlist Manager
Syngene International Ltd Logo
Syngene International Ltd
NSE:SYNGENE
Watchlist
Price: 869.3 INR 2.64% Market Closed
Market Cap: 348.8B INR
Have any thoughts about
Syngene International Ltd?
Write Note

Intrinsic Value

The intrinsic value of one SYNGENE stock under the Base Case scenario is 596.03 INR. Compared to the current market price of 869.3 INR, Syngene International Ltd is Overvalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SYNGENE Intrinsic Value
596.03 INR
Overvaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Syngene International Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SYNGENE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SYNGENE?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Syngene International Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Syngene International Ltd

Provide an overview of the primary business activities
of Syngene International Ltd.

What unique competitive advantages
does Syngene International Ltd hold over its rivals?

What risks and challenges
does Syngene International Ltd face in the near future?

Has there been any significant insider trading activity
in Syngene International Ltd recently?

Summarize the latest earnings call
of Syngene International Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Syngene International Ltd.

Provide P/S
for Syngene International Ltd.

Provide P/E
for Syngene International Ltd.

Provide P/OCF
for Syngene International Ltd.

Provide P/FCFE
for Syngene International Ltd.

Provide P/B
for Syngene International Ltd.

Provide EV/S
for Syngene International Ltd.

Provide EV/GP
for Syngene International Ltd.

Provide EV/EBITDA
for Syngene International Ltd.

Provide EV/EBIT
for Syngene International Ltd.

Provide EV/OCF
for Syngene International Ltd.

Provide EV/FCFF
for Syngene International Ltd.

Provide EV/IC
for Syngene International Ltd.

Show me price targets
for Syngene International Ltd made by professional analysts.

What are the Revenue projections
for Syngene International Ltd?

How accurate were the past Revenue estimates
for Syngene International Ltd?

What are the Net Income projections
for Syngene International Ltd?

How accurate were the past Net Income estimates
for Syngene International Ltd?

What are the EPS projections
for Syngene International Ltd?

How accurate were the past EPS estimates
for Syngene International Ltd?

What are the EBIT projections
for Syngene International Ltd?

How accurate were the past EBIT estimates
for Syngene International Ltd?

Compare the revenue forecasts
for Syngene International Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Syngene International Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Syngene International Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Syngene International Ltd compared to its peers.

Compare the P/E ratios
of Syngene International Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Syngene International Ltd with its peers.

Analyze the financial leverage
of Syngene International Ltd compared to its main competitors.

Show all profitability ratios
for Syngene International Ltd.

Provide ROE
for Syngene International Ltd.

Provide ROA
for Syngene International Ltd.

Provide ROIC
for Syngene International Ltd.

Provide ROCE
for Syngene International Ltd.

Provide Gross Margin
for Syngene International Ltd.

Provide Operating Margin
for Syngene International Ltd.

Provide Net Margin
for Syngene International Ltd.

Provide FCF Margin
for Syngene International Ltd.

Show all solvency ratios
for Syngene International Ltd.

Provide D/E Ratio
for Syngene International Ltd.

Provide D/A Ratio
for Syngene International Ltd.

Provide Interest Coverage Ratio
for Syngene International Ltd.

Provide Altman Z-Score Ratio
for Syngene International Ltd.

Provide Quick Ratio
for Syngene International Ltd.

Provide Current Ratio
for Syngene International Ltd.

Provide Cash Ratio
for Syngene International Ltd.

What is the historical Revenue growth
over the last 5 years for Syngene International Ltd?

What is the historical Net Income growth
over the last 5 years for Syngene International Ltd?

What is the current Free Cash Flow
of Syngene International Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Syngene International Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Syngene International Ltd

Current Assets 18.8B
Cash & Short-Term Investments 10.4B
Receivables 4.8B
Other Current Assets 3.5B
Non-Current Assets 42.6B
Long-Term Investments 1.1B
PP&E 37B
Intangibles 298m
Other Non-Current Assets 4.2B
Current Liabilities 9.4B
Accounts Payable 2.8B
Other Current Liabilities 6.6B
Non-Current Liabilities 8B
Long-Term Debt 5.3B
Other Non-Current Liabilities 2.7B
Efficiency

Earnings Waterfall
Syngene International Ltd

Revenue
34.5B INR
Cost of Revenue
-9.1B INR
Gross Profit
25.4B INR
Operating Expenses
-19.9B INR
Operating Income
5.5B INR
Other Expenses
-680m INR
Net Income
4.8B INR

Free Cash Flow Analysis
Syngene International Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SYNGENE Profitability Score
Profitability Due Diligence

Syngene International Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
59/100
Profitability
Score

Syngene International Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

SYNGENE Solvency Score
Solvency Due Diligence

Syngene International Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
High Interest Coverage
Low D/E
Long-Term Solvency
85/100
Solvency
Score

Syngene International Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SYNGENE Price Targets Summary
Syngene International Ltd

Wall Street analysts forecast SYNGENE stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SYNGENE is 851.83 INR with a low forecast of 707 INR and a high forecast of 1 050 INR.

Lowest
Price Target
707 INR
19% Downside
Average
Price Target
851.83 INR
2% Downside
Highest
Price Target
1 050 INR
21% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SYNGENE?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SYNGENE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SYNGENE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Syngene International Ltd Logo
Syngene International Ltd

Country

India

Industry

Life Sciences Tools & Services

Market Cap

348.8B INR

Dividend Yield

0.14%

Description

Syngene International Ltd. operates as a global discovery, development and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries. The company is headquartered in Bangalore, Karnataka and currently employs 5,975 full-time employees. The company went IPO on 2015-08-11. The firm is engaged in providing services from early discovery and development to commercial manufacturing for small and large molecules. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development, current good manufacturing practice (cGMP) manufacturing, formulation and analytical development along with clinical development services. The company offers SynVent, a therapeutic discovery and development platform for executing drug discovery projects, which is designed to provide a range of advance programs through target validation, translational interrogation, therapeutic discovery and preclinical development for both large and small molecules, as well as specialty modalities, such as targeted protein degradation. The company serves clients ranging from multinational corporations to start-ups.

Contact

KARNATAKA
Bangalore
Syngene International Ltd, Biocon Park, SEZ,, Bommasandra Industrial Area - Phase-IV, Jigani Link Road
+918067758781
www.syngeneintl.com

IPO

2015-08-11

Employees

5 975

Officers

MD, CEO & Executive Director
Mr. Jonathan Brittan Hunt
CFO & Executive Director
Mr. Sibaji Biswas
Chief Scientific Officer
Dr. Jayashree Aiyar Ph.D.
Head of Investor Relations
Krishnan G
Head of Legal, Company Secretary & Compliance Officer
Ms. Priyadarshini Mahapatra C.S.
Head of Corporate Communications
Mr. Sandeep Nair
Show More
Chief Human Resources Officer
Mr. Andrew Webster
Head of Pharmaceutical & Biopharmaceutical Development
Dr. Dhananjay Patankar
Head of Formulations Development
Mr. Purushottam Shashikant Singnurkar
Head of IT
Mr. Ajit Manocha
Show Less

See Also

Discover More
What is the Intrinsic Value of one SYNGENE stock?

The intrinsic value of one SYNGENE stock under the Base Case scenario is 596.03 INR.

Is SYNGENE stock undervalued or overvalued?

Compared to the current market price of 869.3 INR, Syngene International Ltd is Overvalued by 31%.

Back to Top